Study to Promote Innovation in Rural Integrated Telepsychiatry
SPIRIT
Integrated vs. Referral Care for Complex Psychiatric Disorders in Rural FQHCs
1 other identifier
interventional
1,004
1 country
13
Brief Summary
Background: Community Health Centers care for over 20 million rural, low income and minority Americans every year. Patients often have complex mental health problems such as Posttraumatic Stress Disorder (PTSD) and Bipolar Disorder. However, Community Health Centers located in rural areas face substantial challenges to managing these patients due to lack of onsite mental health specialists, stigma and poor geographic access to specialty mental health services in the community. As a consequence, many rural primary care providers feel obligated, yet unprepared, to manage these disorders, and many patients receive inadequate treatment and continue to struggle with their symptoms. While integrated care models and telepsychiatry referral models are both promising approaches to managing patients with complex mental health problems in rural primary care settings, there have been no studies comparing which approach is more effective for which types of patients. Objectives: The central question examined by this study is whether it is better for offsite mental health specialists to support primary care providers' treatment of patients with PTSD and Bipolar Disorder through an integrated care model or to use telemedicine technology to facilitate referrals to offsite mental health specialists. We hypothesize that patients randomized to integrated care will have better outcomes than patients randomized to referral care. Methods: 1,000 primary care patients screening positive for PTSD or Bipolar Disorder will be recruited from Community Health Centers in three states (Arkansas, Michigan and Washington) and randomized to the integrated care model or the referral model. Patient Outcomes: Telephone surveys will be administered to patients at enrollment and at 6 and 12 month follow-ups. Telephone surveys will measure access to care, therapeutic alliance with providers, patient-centeredness, patient activation, satisfaction with care, appointment attendance, medication adherence, self-reported clinical symptoms, medication side-effects, health related quality of life, and progress towards life goals. A sub-sample of patients will be invited to participate in qualitative interviews to describe their treatment experience using their own words. Likewise, primary care providers will be invited to participate in qualitative interviews to voice their perspective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2016
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedDecember 24, 2020
December 1, 2020
3.6 years
April 11, 2016
December 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Mental Health Related Quality of Life
Short Form 12 Mental Health Composite Summary (MCS)
12 month follow-up
Secondary Outcomes (8)
Recovery-oriented outcomes
12 month follow-up
Psychotherapy engagement
Between baseline and 12 month follow-up
Medication Adherence
12 month follow-up
Satisfaction
12 month follow-up
Depression Severity
12 month follow-up
- +3 more secondary outcomes
Other Outcomes (19)
Perceived access to mental health services
6 month follow-up
Perceived access to mental health services
12 month follow-up
Beliefs About Mental Health Treatment
6 month follow-up
- +16 more other outcomes
Study Arms (2)
Integrated Care
ACTIVE COMPARATORTelepsychiatry Collaborative Care
Referral Care
ACTIVE COMPARATORTelepsychiatry Enhanced Referral
Interventions
The telepsychiatrist will also conduct an initial consultation with the patient via interactive video to establish the diagnosis and recommend medications to prescribe. Onsite primary care providers prescribe psychotropic medications. Onsite care managers work with patients either face-to-face or by phone to promote adherence to treatment and assess treatment response. Care managers provide Behavioral Activation either face-to-face or by phone. Care managers have weekly provider-to-provider consultations with the telepsychiatrist to review treatment plans for patients not responding to treatment. The telepsychiatrist will make revised treatment recommendations to the primary care provider.
The offsite telepsychiatrist and/or telepsychologist delivers the treatment via interactive video to patients located at primary care clinics. Telepsychiatrists/telepsychologists administer symptom rating scales at each session. The first encounter will be with the telepsychiatrist to establish diagnosis and develop a treatment plan consisting of algorithm-informed medication management and/or evidence-based psychotherapy. The telepsychiatrists will prescribe medications. Psychotherapy options include Cognitive Processing Therapy and Cognitive Behavioral Therapy. If a patient does not engage in treatment (\<=2 encounters) in the first six months, they will be randomized a second time to continued Telepsychiatry Enhanced Referral or Telephone Enhanced Referral for the second six months. Phone Enhanced Referral involves delivering psychiatric and/or psychological treatment (either initially or exclusively) by telephone to patients in their home.
Eligibility Criteria
You may qualify if:
- Enrolled as a patient at a participating Federally Qualified Health Center
- Screen positive for Bipolar Disorder on the Composite International Diagnostic Interview (CIDI) AND/OR screen positive for PTSD on the PTSD Check List (PCL)-6
You may not qualify if:
- Currently prescribed a psychotropic medication by a mental health specialist.
- Lacks capacity to provide informed consent
- Does not speak English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- University of Arkansascollaborator
- University of Michigancollaborator
- Oregon Health and Science Universitycollaborator
- Washington State Universitycollaborator
- HealthPartners Institutecollaborator
- Kaiser Permanentecollaborator
- Community Health Centers of Arkansascollaborator
- Michigan Primary Care Associationcollaborator
- Community Health Plan of Washingtoncollaborator
Study Sites (13)
Lee County Cooperative Clinic
Marianna, Arkansas, 72301, United States
Boston Mountain Rural Health Centers
Marshall, Arkansas, 72650, United States
East Arkansas Family Health Center
West Memphis, Arkansas, 72301, United States
InterCare Community Health Network
Bangor, Michigan, 49013, United States
Cherry Health
Grand Rapids, Michigan, 49503, United States
Upper Great Lakes Family Health Center
Gwinn, Michigan, 49841, United States
Family Health Center
Kalamazoo, Michigan, 49007, United States
Health Delivery, Inc
Saginaw, Michigan, 48607, United States
Family Medical Center of Michigan
Temperance, Michigan, 48182, United States
Moses Lake Community Health Center
Moses Lake, Washington, 98837, United States
Family Health Centers
Okanogan, Washington, 98840, United States
Sea Mar Community Health Center
Seattle, Washington, 98108, United States
Yakima Neighborhood Health Services
Yakima, Washington, 98907, United States
Related Publications (4)
Severe J, Pfeiffer PN, Palm-Cruz K, Hoeft T, Sripada R, Hawrilenko M, Chen S, Fortney J. Clinical Predictors of Engagement in Teleintegrated Care and Telereferral Care for Complex Psychiatric Disorders in Primary Care: a Randomized Trial. J Gen Intern Med. 2022 Oct;37(13):3361-3367. doi: 10.1007/s11606-021-07343-x. Epub 2022 Feb 2.
PMID: 35106719DERIVEDFortney JC, Bauer AM, Cerimele JM, Pyne JM, Pfeiffer P, Heagerty PJ, Hawrilenko M, Zielinski MJ, Kaysen D, Bowen DJ, Moore DL, Ferro L, Metzger K, Shushan S, Hafer E, Nolan JP, Dalack GW, Unutzer J. Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care: A Pragmatic Randomized Comparative Effectiveness Trial. JAMA Psychiatry. 2021 Nov 1;78(11):1189-1199. doi: 10.1001/jamapsychiatry.2021.2318.
PMID: 34431972DERIVEDFortney JC, Pyne JM, Hawrilenko M, Bechtel JM, Moore D, Nolan JP, Pfeiffer P, Shushan S, Shore JH, Bowen D. Psychometric Properties of the Assessment of Perceived Access to Care (APAC) Instrument. J Ambul Care Manage. 2021 Jan/Mar;44(1):31-45. doi: 10.1097/JAC.0000000000000358.
PMID: 33165120DERIVEDBauer AM, Jakupcak M, Hawrilenko M, Bechtel J, Arao R, Fortney JC. Outcomes of a health informatics technology-supported behavioral activation training for care managers in a collaborative care program. Fam Syst Health. 2021 Mar;39(1):89-100. doi: 10.1037/fsh0000523. Epub 2020 Aug 27.
PMID: 32853001DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Fortney, PhD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Psychiatry and Behavioral Sciences
Study Record Dates
First Submitted
April 11, 2016
First Posted
April 14, 2016
Study Start
November 1, 2016
Primary Completion
June 1, 2020
Study Completion
December 1, 2020
Last Updated
December 24, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will share
If requested by the funding agency (the Patient Centered Outcomes Research Institute), a complete, cleaned and de-identified copy of the final quantitative dataset used to test the stated hypotheses will be made available to other researchers within one year of the study completion date. The final data set will include de-identified demographic and clinical data obtained from the telephone survey for all patients participating in the comparative effectiveness trial. Along with the data set, we will create a code book documenting all variables (e.g., common names for single questionnaire items, and scoring algorithms for derived variables).